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Abstract
Apicomplexan parasites, such as the malaria-causing Plasmodium species, utilize a unique way of locomotion and host cell
invasion. This substrate-dependent gliding motility requires rapid cycling of actin between the monomeric state and very
short, unbranched filaments. Despite the crucial role of actin polymerization for the survival of the malaria parasite, the
majority of Plasmodium cellular actin is present in the monomeric form. Plasmodium lacks most of the canonical actin
nucleators, and formins are essentially the only candidates for this function in all Apicomplexa. The malaria parasite has two
formins, containing conserved formin homology (FH) 2 and rudimentary FH1 domains. Here, we show that Plasmodium
falciparum formin 1 associates with and nucleates both mammalian and Plasmodium actin filaments. Although Plasmodium
profilin alone sequesters actin monomers, thus inhibiting polymerization, its monomer-sequestering activity does not
compete with the nucleating activity of formin 1 at an equimolar profilin-actin ratio. We have determined solution
structures of P. falciparum formin 1 FH2 domain both in the presence and absence of the lasso segment and the FH1
domain, and show that the lasso is required for the assembly of functional dimers.
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Introduction
Apicomplexan parasites comprise an important group of human
and animal pathogens. Best-characterized members of this phylum
are the causative agents of malaria (Plasmodium spp.) and
toxoplasmosis (Toxoplasma gondii). These pathogens share a unique
mode of actin-dependent motility, characterized by the absence of
any specialized organelles or obvious changes in the cell shape [1].
Instead, this so-called gliding motility involves peculiarly short,
unstable actin filaments, which work in concert with an
unconventional myosin, and a small set of regulatory proteins,
governing the rapid cycling of actin monomers back to the
growing end of the filament [2]. This miniature machinery lies in a
confined space between the plasma membrane and the inner
membrane complex of the parasite [3,4] and is linked, through the
plasma membrane, to as-of-yet unidentified host cell receptors
and, through the inner membrane complex, to microtubules in the
cytoplasmic compartment of the parasite [3].
Despite the importance of actin polymerization for the motility
and invasion – and thus survival – of these parasites, most of their
cellular actin is present in monomeric form, and short actin
filaments are formed only transiently [5]. Actin polymerization in
Apicomplexa is controlled by a surprisingly small set of regulatory
proteins and, for example, most of the conventional actin filament
nucleators, such as the Arp2/3 complex and Spire proteins are not
present. The core actin regulators in Plasmodium include two
formins [6], one profilin [7], two actin depolymerization factors
[8,9], two capping protein subunits [10], coronin [11], and a C-
terminal cyclase-associated protein homologue [12].
Formins are a family of large multidomain proteins, important
in many biological processes involving actin polymerization and,
as recently discovered, also microtubule dynamics (reviewed in
[13–15]). They are characterized by the presence of two formin
homology (FH) domains: the filamentous (F)-actin-binding FH2
domain [16,17] and the proline-rich FH1 domain, which in turn
interacts with actin monomers indirectly via other regulatory
proteins, such as profilins [18–20]. Formins work, on the one
hand, as actin nucleators and, on the other, as processive cappers,
which, together with profilins, also accelerate filament growth via
recruiting a large pool of monomeric actin close to the barbed
(growing) end of the filament [16,21,22]. Previous studies, mainly
on mammalian and yeast formins belonging to the mDia family,
have shown that the core FH2 domain alone inhibits actin
polymerization, most likely via binding to the barbed end and
preventing addition of new actin monomers rather than via
monomer sequestering [21,23]. The inclusion of an additional
region N terminal of the core FH2 domain dramatically changes
the properties of formins, turning them into efficient polymeriza-
tion catalysts [23]. This so-called lasso region, linking the FH1 and
FH2 domains, has been shown to form almost the sole contact
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Although the dimeric lasso-containing FH2 domain is sufficient for
both nucleation and elongation of actin filaments [16,21], for most
formins, profilin has been shown to act as a further accelerator,
speeding up polymerization by as much as nearly 20-fold [19].
Formins differ greatly in the number of proline-rich repeats in
their FH1 domains and, thus, in the way they recruit profilin-actin.
Different formins also utilize different profilin isoforms [25].
Apicomplexan genomes encode two to three FH2-domain-
containing formins and a single profilin isoform. Plasmodium
falciparum profilin (Pf-Pfn) binds to proline-rich sequences [7],
indicating that the profilin-formin-mediated regulation of actin
polymerization may be conserved. However, the two Plasmodium
formin isoforms contain only rudimentary FH1 domains, and it is
not clear whether they really participate in the regulation of actin
dynamics in a profilin-dependent manner. In addition, Plasmodium
has a nuclear formin-like protein, which also has a conserved FH2
but no FH1 domain [26]. What is more, none of the regulatory
domains conserved in animal and yeast formins are present in the
apicomplexan counterparts.
P. falciparum formin 1 (Pf-Frm1) and T. gondii formins induce
actin filament formation in vitro using mammalian actin [6,27].
However, until now, it has not been known if the parasite formins
display the same activity also towards parasite actins, which have
dramatically different polymerization properties. Here, we show
that Pf-Frm1 nucleates actin filaments and works on both
mammalian skeletal muscle and Plasmodium actins in vitro. Pf-Pfn
alone sequesters actin monomers, inhibiting polymerization, and
has little or no effect on polymerization in the presence of different
Pf-Frm1 variants. Pf-Frm1 dimerizes in solution, and the lasso
domain, preceding the core FH2 domain, is required for the
assembly of functional dimers, and thus, the nucleation activity of
Pf-Frm1.
Materials and Methods
Cloning and recombinant protein expression and
purification
The gene encoding P. falciparum formin 1 FH1 and FH2
domains (Pf-Frm1-FH1FH2; (amino acids 2203–2675)) was
amplified from genomic DNA 3D7 clone of P. falciparum and
inserted into the pETM-11 (EMBL) vector using the NcoI and XhoI
restriction sites. Two shorter constructs, lacking the FH1 domain
or the FH1 domain and the so-called lasso segment (Pf-Frm1-FH2;
amino acids 2242–2672 and Pf-Frm1-FH2Dlasso; amino acids
2272–2672, respectively) were amplified from this vector, and
inserts were assembled using multi-tier sequence and ligation
independent cloning (SLIC; [28]) into a PCR-linearized pETM-14
(EMBL) vector followed by annealing. The plasmids were
transformed into Escherichia coli Rosetta(DE3) (Novagen), the
recombinant proteins were expressed using 1 mM isopropyl-b-D-
1-thiogalactopyranoside-induction at 18uC overnight in lysogeny
broth (LB). The hexa-histidine (66His)-tagged formins were
purified on a Ni-NTA column (GE Healthcare) under native
conditions in a buffer containing 50 mM sodium phosphate
(pH 7.5), 300 mM NaCl, and 5 mM b-mercaptoethanol. A
gradient of 10 to 500 mM imidazole in the same buffer was used
for eluting the proteins. The 66His-tags were cleaved during
overnight dialysis against 40 mM tris(hydroxymethyl)amino-
methane (Tris)-HCl (pH 7.5), 100 mM NaCl, 10% glycerol, and
1 mM dithiothreitol (DTT) in the presence of either tobacco etch
virus (Pf-Frm1-FH1FH2) or human rhinovirus 3C (Pf-Frm1-FH2
and Pf-Frm1-FH2Dlasso) protease. Uncleaved proteins and
66His-tagged proteases were removed by binding to a Ni-NTA
column, and the flow-through fractions were concentrated and
applied to a Superdex 200 16/60 column (GE Healthcare),
equilibrated with 40 mM Tris-HCl (pH 7.5), 100 mM NaCl, 10%
glycerol, and 1 mM DTT. Purified proteins were concentrated
and stored at 270uC until use in assays.
The gene encoding Pf-Pfn was cloned into the pGAT-2 vector
[29], which contains a thrombin cleavage site after the 66His-
glutathione-S-transferase (GST) tag, using the NcoI and XhoI
restriction sites. The protein was expressed in E. coli BL21(DE3),
and the 66His-GST-Pf-Pfn was purified essentially as described
before [7], using a HisTrap column (GE Healthcare). After dialysis
into 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, and 5% glycerol,
Pf-Pfn was released from the 66His-GST tag using thrombin (GE
Healthcare). The cleaved Pf-Pfn was then passed through a
HisTrap column, and the flow-through was subjected to size
exclusion chromatography (SEC) over a Superdex 200 16/60
column (GE Healthcare) in 10 mM Tris-HCl (pH 7.5) and
100 mM NaCl. Peak fractions were collected, concentrated, and
stored on ice for subsequent experiments.
Genes encoding P. falciparum actin 1 (Pf-Act1) and P. berghei actin
2( Pb-Act2) were synthesized and codon-optimized for insect cell
expression by Mr. Gene (now part of Invitrogen). The Pf-Act1 gene
was cloned into the pFastBac-HTA vector (Invitrogen) using the
NcoI and XhoI sites. The cloned plasmid was transformed into
DH10Bac (Invitrogen) cells for bacmid generation. Sf9 (Invitro-
gen) cells were transfected with the Pf-Act1 bacmid using the
FuGene 6 transfection reagent (Roche), and virus particles were
harvested after 3 days of infection and used to generate a high-titer
viral stock. Typically, 400 ml of the high-titer virus was used to
infect approximately 2610
8 cells. The cells were harvested three
days after infection, and the cell pellets were stored at 220uC.
Pb-Act2 and a 66His-tag from the pETM-14 vector (EMBL)
were amplified, and the inserts were assembled using multi-tier
SLIC, as described before [28] into the pFastBac-Dual vector
(Invitrogen), digested with EcoRI and XbaI. Pb-Act2 was produced
in Sf21 (Invitrogen) cells essentially as described before [30].
Briefly, Sf21 cells were transfected with a bacmid generated in and
isolated from the DH10MultiBac strain, using the FuGene 6
transfection reagent (Roche). The released virus particles were
collected and used to generate a high-titer viral stock. Typically,
400 ml of the high-titer virus was used to infect 2610
8 cells. 60–
70 h after the growth arrest, cells were harvested and stored at
220uC.
For purification of recombinant Pf-Act1 and Pb-Act2, the cells
were resuspended in lysis buffer [20 mM N-cyclohexyl-2-ami-
noethanesulfonic acid pH 9.5, 250 mM NaCl, 1 mM adenosine-
59-triphosphate (ATP), 2 mM b-mercaptoethanol, 20 mM imid-
azole, 16cOmplete Mini EDTA free (Roche)] and sonicated for
15 s. The supernatant was clarified by centrifugation at 18000 g
and applied to Ni-NTA agarose (Qiagen). After extensive washing
with the lysis buffer, the final washes were performed in a modified
G-buffer [5 mM Tris-HCl (pH 8.0), 0.2 mM CaCl2, 0.5 mM
ATP, and 2 mM b-mercaptoethanol], supplemented with 20 mM
imidazole, and the bound proteins were eluted with the modified
G-buffer, containing 300 mM imidazole. Subsequently, the
proteins were dialyzed against G-buffer [5 mM Tris-HCl
(pH 8.0), 0.2 mM CaCl2, 0.5 mM ATP, and 5 mM DTT]
overnight at 4uC, concentrated, stored on ice, and used within a
week.
Skeletal muscle actin preparation
Pig loin muscle was obtained from pigs from the University of
Oulu Laboratory Animal Centre. The study plan was reviewed
and accepted by the local ethics committee of the University of
Dimerization and Activity of Plasmodium Formin 1
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According to the Finnish legislation, no official license for animal
experiments was needed because the tissues were collected from
animals euthanized using a method accepted by law. Because of
ethical reasons, and to fulfil the principle of reduction, the tissues
were collected from animals, which were used in other animal
experiments, for which there was a separate license from the
Finnish National Animal Experiment Board. Essentially, muscle
acetone powder preparation and actin purification were per-
formed as described previously [31]. Prior to use in experiments,
SEC was carried out in G-buffer over a Superdex 200 16/60
column (GE Healthcare). Pure monomeric actin was stored on ice
and used within a week.
Synchrotron radiation circular dichroism spectroscopy
For synchrotron radiation circular dichroism (SRCD) measure-
ments, the formin samples were dialyzed into 10 mM potassium
phosphate buffer, pH 7.0, and the concentrations were adjusted to
1.1–1.5 mg/ml. SRCD data were measured on beamline CD1 at
the ASTRID synchrotron storage ring, ISA, University of Aarhus,
Denmark. Each sample was scanned from 280 to 170 nm in a
100-mm pathlength circular quartz cuvette. Three consecutive
scans of each sample were performed, and the corresponding
buffer spectrum was subtracted. SRCD data were processed using
CDtool [32], and secondary structure deconvolution was carried
out at the Dichroweb server [33], using the CDSSTR algorithm
[34] and the SP175 reference database [35].
Molecular weight determination by multi-angle static
light scattering
Analytical SEC was carried out by injecting 200 ml of each of
the three formin samples at 1 mg/ml into a Superdex 200 10/300
GL column (GE Healthcare) coupled to an A ¨kta Purifier (GE
Healthcare). The running buffer was 50 mM sodium phosphate
(pH 7.0), 50 mM NaCl, and 1 mM DTT, and the flow rate was
0.5 ml/min. The system was attached to a mini-DAWN TREOS
multi-angle static light scattering (MALS) detector (Wyatt) and an
Optilab rEX differential refractometer (Wyatt) for absolute
molecular weight determination. Molecular weights were deter-
mined based on the measured light scattering and refractive index
and/or UV absorbance using the ASTRA software (Wyatt).
Small-angle scattering
Synchrotron small-angle X-ray scattering (SAXS) measure-
ments were carried out on beamlines X33 (DORIS storage ring)
and P12 (PETRA III) at EMBL/DESY, Hamburg, and on
beamlines I711 and I911-4 at MAX-Lab, Lund. Protein
concentrations in the measurements varied between 3–20 mg/
ml, in a buffer containing either 20 mM Tris-HCl (pH 7.5),
150 mM NaCl, and 1 mM DTT (Pf-Frm1-FH1FH2) or 25 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES;
pH 7.5), 150 mM NaCl, and 1 mM DTT (Pf-Frm1-FH2 and Pf-
Frm1-FH2Dlasso). Programs of the ATSAS package [36] were
used for data processing and analysis. 3D models were built using
DAMMIN [37], DAMMIF [38], GASBOR [39], SASREF [40],
and BUNCH [40]. SUPCOMB [41] and DAMAVER [42] were
used for superpositions and the calculation of averaged models,
respectively. A homology model of the Pf-Frm1 FH2 domain,
consisting of 435 residues, including the core FH2 domain, the
linker, and the lasso, was built based on PDB entry 3O4X [43] as a
template, using the Phyre2 server [44]. The sequence alignment
gives 23% sequence identity, and the Phyre confidence score for
the model is 100%. For BUNCH modeling, the linker and lasso
were removed from the homology model and rebuilt as a chain-
like model. Rigid body modeling with SASREF was done using
two approaches: First, the two protein chains from the homology
model were used for rigid body refinement per se. Second, to mimic
flexibility of the linker, while keeping the lasso-knob interaction in
place, the dimer homology model was cut in half at each of the
linker domains, between residues 104 and 105. Hence, rigid body
refinement was carried out with two halves of the dimer, each of
which contained, in addition to the FH2 domain, the lasso domain
from the other subunit instead of the one from the same chain.
For small-angle neutron scattering (SANS), Pf-Frm1-FH1FH2
was dialyzed against 4 mM HEPES (pH 7.5), 20 mM NaCl, in
98% D2O. SANS data were collected on beamline SANS1 at
GKSS (Geesthacht, Germany), and were processed on absolute
scale.
Biochemical assays
For co-sedimentation assays, 5 mM ATP-actin - either pig
skeletal muscle actin or recombinant Pf-Act1/Pb-Act2 - was
incubated in G- [5 mM Tris-HCl (pH 7.5), 0.2 mM CaCl2,
0.2 mM ATP, and 0.5 mM DTT] or F-buffer (G-buffer including
2 mM MgCl2, 50 mM KCl, and 2 mM ATP), alone and with
250 nM formins, at room temperature for 1–2 h. After ultracen-
trifugation at 435000 g for 60 min at 20uC, equal amounts of the
supernatants and pellets were analyzed by sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and
Coomassie Brilliant Blue staining.
Actin polymerization was investigated at 22uC by fluorescence
spectroscopy in a 200-ml quartz cuvette by measuring the change
in fluorescence intensity (excitation 365 nm, emission 407 nm,
bandpass 2 nm for both excitation and emission) with a Horiba
Scientific FluoroMax-4 spectrofluorometer. Unlabeled pig muscle
actin (5 mM) containing 5% pyrene-labeled rabbit actin (Cyto-
skeleton Inc.) was in G-buffer. Actin polymerization was initiated
by adding 1/10 of the volume of 106 F-buffer (to a final
concentration of 50 mM KCl, 2 mM MgCl2, and 2 mM ATP), in
the presence of 0, 1, 5, 10, or 50 nM of the different Pf-Frm1
variants. The change in fluorescence intensity was followed for
1000 s at 10-s intervals. To assess the effect of Pf-Pfn on the
polymerization kinetics, the assay was also performed with 5 and
10 mM Pf-Pfn in both presence and absence of 10 nM formins.
The measurements were performed in duplicate, and averages of
the individual measurements were compared.
Results
Plasmodium falciparum formin 1 forms stable dimers
mediated by the lasso segment in solution
We expressed and purified three different variants of Pf-Frm1
(Figure 1A): (i) the FH1-FH2 domains together (Pf-Frm1-
FH1FH2), (ii) a longer version of the FH2 domain, which contains
the so-called lasso region (Pf-Frm1-FH2), and (iii) a shorter version
of the FH2 domain (Pf-Frm1-FH2Dlasso). SEC indicated an
apparent dimer size for the two longer Pf-Frm1 proteins, whereas
Pf-Frm1-FH2Dlasso appeared to be mainly monomeric, with a
small fraction eluting earlier than the longer Pf-Frm1 dimers from
the column (Figure 1B). However, as SEC does not give direct
information on the molecular weight but rather the shape of the
molecule, we used MALS to determine the true oligomeric state of
each protein (Figure 1B, Table 1). The light scattering profiles,
indeed, confirm that Pf-Frm1-FH1FH2 and Pf-Frm1-FH2 are
dimeric in solution, with molecular weights of 105.0 kDa (61%)
and 98.2 kDa (63%), respectively, whereas the majority of Pf-
Frm1-FH2Dlasso is monomeric with a molecular weight of
Dimerization and Activity of Plasmodium Formin 1
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earlier is 99.0 kDa (66%), indicating that Pf-Frm1-FH2Dlasso also
has the tendency to form dimers, which are not as tight and are
less compact than the dimers of Pf-Frm1-FH1FH2 and Pf-Frm1-
FH2.
In order to confirm the above findings and to determine the 3D
shapes of the different Pf-Frm1 variants, we studied their solution
structures using synchrotron SAXS (Figure 2A,B). The basic data
extracted from the SAXS scattering curves (Table 1) indicate that
the construct with the lasso, but without the rudimentary FH1
domain (Pf-Frm1-FH2), is the most compact of the three
constructs. While this was expected in comparison to Pf-Frm1-
FH1FH2, it is surprising that the shorter construct, Pf-Frm1-
FH2Dlasso, is more extended. The Pf-Frm1-FH1FH2 construct
was also studied with SANS (Figure 2C). The neutron scattering
curve had a similar shape to the SAXS curve, indicating the
sample suffered no significant damage from X-rays during the
SAXS measurement.
Ab initio model building further confirmed the presence of a
compact dimer in the Pf-Frm1-FH2 construct. The longer Pf-Frm1-
FH1FH2 is similar, with slightly longer dimensions, in line with the
presence of 30 additional N-terminal amino acids, predicted to be
unfolded (Figure 2D,E). However, the shortest construct, Pf-Frm1-
FH2Dlasso, is significantly different, being less compact (Figure 2F).
While it appeared to be largely dimeric at the concentration used in
the SAXS experiments, no compact dimer, such as that seen in the
other constructs, was observed. The ab initio model built based on
the data is elongated, S-shaped, and thin. Furthermore, analysis of
the SAXS data indicates this construct to most likely be present as a
mixture of monomeric and dimeric forms, which is in line with the
SEC/MALS results. Taken together, the data clearly show that the
absence of the lasso segment interferes with the dimerization of the
formin FH2 domain in solution, resulting also in loss of function of
the protein, as presented below.
We also used SRCD spectroscopy to assess the folding state and
secondary structure composition of the different formin variants
(Figure 2G). Pf-Frm1-FH1FH2 contains 501 amino acid residues,
and according to the deconvolution, out of these, 46% (230
residues) are in an a-helical conformation, 9% are in b strands,
13% in turns, and 31% (155 residues) do not form any secondary
structure. As FH2 domains are mainly helical, this result is in
agreement with known FH2 domain structures and secondary
structure predictions. Pf-Frm1-FH2 consists of 450 residues, of
which approximately 234 are in a helices and 113 are unordered.
The result clearly proves that the FH1 domain is unfolded. Pf-
Frm1-FH2Dlasso has 420 residues, of which approximately 223
are in a helices and 113 unordered. In addition to the predicted
presence of a short helical stretch in the lasso, it is likely that the
lack of the lasso segment and proper dimerization in the shortest
construct leads to some degree of unfolding. This is also in line
with the SAXS data, showing a more elongated structure than for
the lasso-containing construct.
Figure 1. Purification and characterization of the recombinant
proteins. A, SDS-PAGE analysis showing the purity of the proteins
used in this study. The gel was stained using Coomassie Brilliant Blue.
The samples are 1. Pf-Frm1-FH1FH2, 2. Pf-Frm1-FH2, 3. Pf-Frm1-
FH2Dlasso, 4. pig muscle actin, 5. Pf-Act1, 6. Pb-Act2, and 7. Pf-Pfn.
The molecular weights of the standard proteins in kDa are indicated on
the right. The differences in the molecular weights of the Plasmodium
and pig actins are accounted for by the 66His-tags present in the
recombinant Plasmodium actins. B, Size-exclusion chromatograms
showing a single peak for Pf-Frm1-FH1FH2 (red) and Pf-Frm1-FH2
(blue) and two peaks for Pf-Frm1-FH2Dlasso (green). The molecular
weights of the peaks of Pf-Frm1-FH1FH2 and Pf-Frm1-FH2 correspond
to the size of dimers, and the two peaks of Pf-Frm1-FH2Dlasso to a
dimer and a monomer, as determined by MALS (vertical lines with
colors corresponding to those of the chromatograms).
doi:10.1371/journal.pone.0033586.g001
Table 1. Properties of the three formin versions derived from SEC/MALS and SAXS.
Sample Monomer MW








Chi, model vs. data (DAMMIN,
DAMMIF, GASBOR, BUNCH)
Pf-Frm1-FH1FH2 57.7 105.0 (61%) 6.4 25 352 0.9, 1.1, 1.1, 1.4
Pf-Frm1-FH2 52.3 98.2 (63%) 5.2 19 335 1.2, 1.2, 1.7, -
Pf-Frm1-FH2Dlasso 48.8 major peak: 54.9 (66%), minor peak: 99.0
(66%)
6.7 23 299 1.3, 2.2, 2.1, -
The given volume is that of the respective averaged ab initio dummy bead model. The Chi-value describes the fit between the experimental scattering data and the
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filaments, and the lasso-mediated dimerization is
required for this activity
It has previously been shown that the FH1-FH2 and FH2
domains of Pf-Frm1 nucleate filaments of chicken actin [6]. To
evaluate the activities of the three Pf-Frm1 variants on Plasmodium
actins, we performed co-sedimentation assays by ultracentrifuga-
tion, using recombinant Pf-Act1 and Pb-Act2. In low-salt
conditions (G-buffer), we see that all three Pf-Frm1 versions
induce the Plasmodium actins to polymerize to some extent
(Figure 3A). All three formins appear to alone partially pellet in
the low-salt condition, indicating that they are not very stable in
Figure 2. Solution structures of the Pf-Frm1 domains. A, Raw synchrotron SAXS data for Pf-Frm1-FH1FH2 (red), Pf-Frm1-FH2 (blue), and Pf-
Frm1-FH2Dlasso (green). B, Distance distribution functions derived from the SAXS data; coloring as in panel A. C, SANS data for Pf-Frm1-FH1FH2. A
radius of gyration (Rg) of 5.7 nm and a maximum particle dimension (Dmax) of 18 nm can be estimated from the data. D, Averaged ab initio dummy
atom models for Pf-Frm1-FH1FH2 (red) and Pf-Frm1-FH2 (blue) created by DAMMIN. The extensions at the extremities most likely correspond to the
FH1 domain. E, Averaged ab initio models for Pf-Frm1-FH2 created by DAMMIN (blue) and GASBOR (cyan). The two figures are related by a 90u
rotation about the X-axis. Both methods produce very similar models that fit the data. F, Averaged ab initio model for Pf-Frm1-FH2Dlasso (green)
created by DAMMIN, superimposed on the structure of Pf-Frm1-FH1FH2 (red). Note that Pf-Frm1-FH2Dlasso is highly elongated, lacking a compact
domain in the middle. G, SRCD spectra for the Pf-Frm1 variants. Coloring as in panel A. Pf-Frm1-FH2 has the highest relative helical content; see text
for details on spectral deconvolution.
doi:10.1371/journal.pone.0033586.g002
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part of the proteins is soluble also in G-buffer and upon addition of
actin completely moves to the pellet fraction, taking along
approximately half of Pf-Act1 and Pb-Act2, which both alone in
G-buffer are completely soluble.
In typical polymerization conditions with a high salt concen-
tration (F-buffer), both Plasmodium actins polymerize completely
under the conditions used in the assay. All three Pf-Frm1 versions
nearly quantitatively co-sediment with the actin filaments
(Figure 3B), while they are mostly soluble in F-buffer in the
absence of actin, proving that they tightly associate with actin
filaments. There is some Pf-Frm1-FH2Dlasso left in the soluble
fraction in F-buffer with actin. However, it is not possible to see
how much of it is in the pellet, as Pf-Frm1-FH2Dlasso is not well
separated from the Plasmodium actins on the gels. As a control, the
experiment in F-buffer was also performed using pig skeletal
muscle actin. As expected, all formins associate with the actin
filaments and are found in the pellet fractions (Figure 3C). It is
noteworthy that the pig actin allows for a better separation of the
actin and Pf-Frm1-FH2Dlasso.
To further characterize the activities of the different length
formins, we performed polymerization assays using pig muscle
actin and monitoring the increase in fluorescence upon co-
polymerization of 5% pyrene-labeled actin (Figure 4). Already
5n MPf-Frm1-FH1FH2 and Pf-Frm1-FH2 significantly accel-
erated the initial rate of polymerization (Figures 4A–D),
indicating participation in the nucleation of actin filaments.
However, Pf-Frm1-FH2Dlasso had no significant effect on the
polymerization rate at the concentrations used (Figure 4E,F).
T h u s ,t h eF H 2d o m a i nd i m e r ,m e d i a t e db yt h el a s s or e g i o n ,i s
both necessary and sufficient for the nucleation activity of Pf-
Frm1.
Figure 3. Co-sedimentation of Pf-Frm1 with Plasmodium and pig actins. A, Pf-Frm1 induces actin polymerization in low-salt conditions. Pf-
Act1 and Pb-Act2 were incubated alone and in the presence of Pf-Frm1-FH1FH2, Pf-Frm1-FH2, and Pf-Frm1-FH2Dlasso in G-buffer, followed by
ultracentrifugation at 435000 g. The supernatants and pellets were separated, and equal amounts were applied to the SDS gel, which was stained
with Coomassie Brilliant Blue. The supernatants and pellets are labeled at the bottom of the gel as S and P, respectively. The presence or absence of
the different Pf-Frm versions is indicated with + and 2 signs above. The first eight lanes contain Pf-Act1, the next eight Pb-Act2, and the last six only
the formins in G-buffer. B, All three Pf-Frm versions associate with Plasmodium actin filaments. The actins were allowed to polymerize in the presence
or absence of the formins in F-buffer and separated on SDS-PAGE, as in panel A. The first eight lanes contain Pf-Act1, the next eight Pb-Act2, and the
last six only the formins in F-buffer. The arrowhead shows the small amount of Pf-Frm1-FH2Dlasso left in the soluble fraction in the presence of Pb-
Act2 in F-buffer. C, All three formins also co-sediment with pig muscle actin. The experiment was performed as in panel B, and the presence or
absence of the formins is indicated above the figure. The molecular weight standards of 70, 55, and 40 kDa are indicated. The same standards were
used in all gels shown. The arrowheads indicate the positions of actin, Pf-Frm1-FH1FH2, Pf-Frm1-FH2, and Pf-Frm1-FH2Dlasso in the gel, from left to
right.
doi:10.1371/journal.pone.0033586.g003
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monomers alone but has little effect on actin
polymerization in the presence of formin 1
In order to assess whether Plasmodium profilin works together
with Pf-Frm1 to accelerate actin polymerization, we performed
pyrene-actin fluorescence polymerization assays also in the
presence of Pf-Pfn. As expected, based on the function of profilins
from other species, Pf-Pfn alone inhibits actin polymerization
(Figure 5). However, together with the different Pf-Frm1 domains
used, Pf-Pfn at an equimolar ratio to actin had little or no effect
either on the initial rate or the total amount of actin
polymerization (Figure 5). At a 2:1 profilin-actin ratio, profilin
Figure 4. Effect of Pf-Frm1 on actin polymerization kinetics. The effect of Pf-Frm1 on the kinetics of actin polymerization was tested by
measuring the change in fluorescence upon incorporation of 5% pyrene-actin into growing actin polymers. The actin concentration used in all
experiments was 5 mM. The initial rates (DF/s) were calculated as the slope of the linear part (120 s) of the fluorescence curves. In order to facilitate
comparison, the samples containing only actin were set to the value 1. A–B, Different concentrations of Pf-Frm1-FH1FH2. C–D, Different
concentrations of Pf-Frm1-FH2. E–F, Different concentrations of Pf-Frm1-FH2Dlasso.
doi:10.1371/journal.pone.0033586.g004
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of formins. Thus, we can conclude that Pf-Pfn either binds to actin
with a lower affinity than Pf-Frm1 or that Pf-Frm1 nucleates and
elongates profilin-actin even in the absence of a canonical profilin-
binding FH1 domain.
Discussion
Our current view of the actin-based motility of apicomplexan
parasites is somewhat controversial; despite the importance of
rapid formation of actin filaments, most of apicomplexan actin is
present in the monomeric state [5]. The system also seems rather
vulnerable due to the very small number of actin-binding proteins
taking part in the rapid treadmilling of actin in the parasites.
Especially perplexing is the lack of most of the conventional actin
nucleators - while fast nucleation would seem more important than
elongation in a system, where only very short, transient actin
filaments are required. In essence, the only candidates for actin
nucleation in Plasmodium and other Apicomplexa are the formins.
Formins in most organisms work as nucleators and processive
cappers, protecting the barbed end from capping proteins and
accelerating the rate of polymerization by recruiting profilin-actin
complexes via their proline-rich FH1 domains [19]. We show here
that Pf-Frm1 promotes actin filament assembly on both mamma-
lian skeletal muscle and recombinant Plasmodium actins, suggesting
a major role in actin filament nucleation in Plasmodium.
Figure 5. Effect of Pf-Pfn on actin polymerization kinetics in the presence of Pf-Frm1. The effect of Pf-Pfn added at a 1:1 or 2:1 molar ratio
to actin on the kinetics of actin polymerization in the presence of the different Pf-Frm1 domains was tested by measuring the change in fluorescence
upon incorporation of 5% pyrene-actin into growing actin polymers. The actin concentration used in all experiments was 5 mM. A, Pf-Pfn together
with 10 nM Pf-Frm1-FH1FH2. B, Pf-Pfn together with 10 nM Pf-Frm1-FH2. C, Pf-Pfn together with 10 nM Pf-Frm1-FH2Dlasso.
doi:10.1371/journal.pone.0033586.g005
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compared to conventional actins [5,45]. Yet, we see both
Plasmodium actins almost completely polymerizing in the pelleting
assay, in the absence of any nucleators or filament-stabilizing
agents. All three Pf-Frm1 constructs studied here associate with the
actin filaments and, interestingly, nearly completely co-sediment
with the filaments, indicating that, in addition to the growing ends,
they may also bind to the sides of the filaments, as has been
suggested earlier for e.g. the Drosophila melanogaster formin DAAM
[46]. Although bundling has not been shown to happen in
apicomplexan actins, this raises the question whether Pf-Frm1
could play a role in bundling and cross-linking of the short parasite
actin filaments.
We show that dimerization of the Pf-Frm1 FH2 domain is
mediated by the lasso region N terminal to the core FH2 domain,
and the formation of a compact FH2 dimer is important for Pf-
Frm1 activity. Furthermore, the Pf-Frm1 FH2 domain also weakly
induces actin polymerization in low-salt conditions, which
indicates a strong interaction and nucleating activity with actin.
In our assays, approximately 5 nM Pf-Frm1-FH1FH2 and Pf-
Frm1-FH2 were sufficient for an increase in the initial actin
polymerization rate. This is in agreement with what has been
reported before for both Plasmodium and Toxoplasma formins, where
low nanomolar formin concentrations were enough for a
significant increase in the polymerization rates [6,27].
Pf-Frm1 lacks a well-defined FH1 domain and has, instead, only
few proline residues scattered in the region preceding the FH2
domain. Consistent with the lack of proline-rich repeats in the Pf-
Frm1 sequence, we have not detected an interaction between Pf-
Frm1 and Pf-Pfn, using purified recombinant proteins in GST
pull-down assays and SEC (unpublished data). Therefore, it is not
unexpected that Pf-Pfn had very little, if any, effect on actin
polymerization kinetics in the presence of Pf-Frm1. It seems likely
that the role of Pf-Pfn is, indeed, to efficiently bind actin
monomers in a form that facilitates their incorporation to the
barbed ends of the growing actin filaments.
Previously, we have shown that Pf-Pfn binds to proline-rich
sequences [7]. Interestingly, the Plasmodium formin 2 isoform
contains in its putative FH1 domain two potential profilin-binding
regions. It is remarkable that, although T. gondii profilin is highly
conserved with Pf-Pfn, it has been reported to be unable to bind
proline-rich sequences [27,47]. The apicomplexan profilins are
very distantly related to profilins from other phyla but the P.
falciparum and T. gondii profilins are 42% identical. In Pf-Pfn, the
aromatic nature of the proline-rich-peptide binding site is
conserved but many of the exact amino acid positions are not
[7]. The same is true for T. gondii profilin [47], and furthermore,
there are differences in the aromatic residues of the peptide-
binding surface of these two apicomplexan profilins, as well.
Therefore, it is possible that they have somewhat divergent
functions and mechanisms. Despite the similarities in the actin
structures and their regulation in these two parasites, there are also
significant differences, which at least partly might be due to the
very different life cycles of Plasmodium and Toxoplasma. Whereas
Toxoplasma only uses mammalian hosts and displays virtually no
cell specificity, Plasmodium needs both a mammalian and an
arthropod host and is highly specific with regard to its host cells,
depending on the life cycle stage. Furthermore, Plasmodium has two
actin isoforms and Toxoplasma only one [48–50]. Therefore, the
differences in the actin regulatory proteins may reflect adaptations
to both differential actin isoforms and also different mechanisms
needed to enter and survive within different host cells.
Our data support the role of a G-actin sequesterer for
Plasmodium profilin but do not exclude the possibility that it works
together with Plasmodium formin 2 to accelerate elongation, like in
most other organisms. This implies that Plasmodium could have two
diverged formins; one functioning rather as a sole nucleator and
the other one also as an elongation factor together with profilin.
Apparently, in Toxoplasma, such a difference does not exist [27].
For Plasmodium, this remains to be seen, once Plasmodium formin 2
has been properly characterized.
From the structural point of view, our data indicate that the
dimeric structure of Pf-Frm1-FH2 in solution is similar to that seen
e.g. in the crystal structure of the mouse mDia1 (PDB code 3O4X)
[43] (Figure 6). The mouse mDia1 and Pf-Frm1 FH2 domains
have 23% sequence identity (Figure 6A). The flexible linker region
between the lasso segment and the core FH2 domain provides
adaptability that is required for interactions with actin; in the
actin-bound state, two actin monomers are bound between the
core FH2 domains. Modeling of Pf-Frm1-FH1FH2 using the core
FH2 domain and chain-like fragments, with the BUNCH
software, provides also a dimeric model, which fits the scattering
data very well, while preserving the expected intermolecular
interactions (Figure 6B). From other formin FH2 domain
structures, it is predicted that the lasso segment wraps around
the so-called post region of the opposing FH2 monomer
[24,43,51–53] (Figure 6C). From rigid body modeling using a
homology model of the dimer (Figure S1), it is seen that rather
minor rearrangements of the mDia1 dimer, which can be obtained
from some flexibility in the linker region, result in a model that fits
the SAXS data very well. The head-to-tail 2-fold symmetrical
arrangement of the FH2 domain dimer, combined with the
expected flexibility of the linker region between the FH2 and the
lasso domains, provides a versatile framework for the binding of
actin dimers by the dimerized FH2 domain. In the co-
sedimentation assays (Figure 3) we see that all three formin
versions associate with actin filaments and also induce formation of
filaments in low-salt conditions. However, in the pyrene-actin
fluorescence polymerization assay (Figure 4), only the two longer,
dimeric versions increase the polymerization rate. It is possible
that the FH2 domain in the absence of the lasso and, thus, proper
dimerization still binds to actin filaments, as seen before for mouse
mDia1 and mDia3 core FH2 domains [23]. Our results indicate
that Pf-Frm1-FH2Dlasso is also somehow capable of bringing
together actin monomers as short filament nuclei or aggregates,
which are large enough to sediment at 435000 g, but cannot
support further elongation of the filaments.
Our SAXS and SRCD data also prove that, as predicted based
on the sequence, but to our knowledge not visualized for any
formin before, the FH1-like domain of Pf-Frm1 is unstructured,
and presents itself as two protrusions at opposite ends of the head-
to-tail FH2 domain dimer.
Concluding remarks
We have shown that Pf-Frm1 is capable of initiating actin
filament formation on both skeletal muscle as well as Plasmodium
actins. This is the first time that such a polymerization promoting
effect has been shown for purified, recombinant Plasmodium actins.
This confirms Pf-Frm1 to be the prime candidate responsible for
actin filament nucleation in these parasites. Our data also show
that, while Pf-Pfn efficiently sequesters monomers, its monomer
sequestering activity does not compete with the nucleation/
elongation activities of Pf-Frm1. This, indeed, emphasizes the role
of profilin in providing polymerization competent actin monomers
to be added to the growing end of an actin filament – probably
even in the absence of a direct interaction between profilin and a
formin FH1 domain.
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PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e33586In addition, we provide the first structural insight into the
dimerization of an apicomplexan formin and prove its relevance
for the actin polymerizing activity. The solution structures
presented here serve as a first step towards understanding the
structure-function relationships in these multidomain proteins. In
order to understand the complex interplay between the malaria
parasite formins, actin, and other regulatory proteins interacting
with them, more structural work at different levels of resolution is
of crucial importance.
Supporting Information
Figure S1 Comparison of different models of Pf-Frm1
FH2 domain to the SAXS data. A, Three models are shown:
orange, the homology model based on the mDia1 structure (PDB
entry 3O4X [43]) – also shown in Fig. 6B superimposed on the
BUNCH model; green, a model of the dimer obtained by rigid
body refinement of the two FH2 domain chains from the
homology model; blue, a rigid body model obtained from two
halves of the dimer, such that there is a cut in the linker between
residues 104 and 105 (blue arrows). Hence, in the refinement, the
lasso belongs to the same rigid body as the corresponding knob.
The locations of the lasso segments are indicated by circles. The
two monomers in each model are colored slightly differently for
clarity. B, Fit (red) of the BUNCH model shown in Fig. 6B to the
scattering data of Pf-Frm1-FH1FH2 (black dots). C, Fits of the 3
models shown in A to the scattering data of Pf-Frm1-FH2,
corresponding to the model. Coloring of the fits corresponds to the
coloring of the respective models in A. The small changes in the
dimer conformation in the rigid body models improve the fit
significantly.
(TIF)
Figure 6. Model for the dimerization of Plasmodium formin 1. A, Sequence alignment between the Pf-Frm1 FH2 domain and the best
template identified by Phyre for homology modeling (mouse mDia1 [43]). Pf-Frm1-FH2 includes both the lasso and linker domains, while Pf-Frm1-
FH2Dlasso has only the linker segment. B, Comparison of the dimer homology model of Pf-Frm1 (shown as cartoons; the dimerization in the model is
built identical to that seen in the mDia1 template structure 3O4X [43]) with the SAXS model built by using the core FH2 domains as rigid bodies
(green) and building the linker, lasso, and FH1 segments by chain-like assemblies of dummy residues (cyan). The SAXS model was made with BUNCH,
applying P2 symmetry, but no distance restraints. The Chi-value against the raw SAXS data is 1.4, reflecting a very good fit to the measurement; the fit
is shown in Figure S1B. Figure S1 also contains further rigid body refinement analysis of the homology model. C, A close-up view into the model of
the lasso segment (green) in a Pf-Frm1 dimer; the FH2 domain monomers are indicated in blue and red. The orange segment represents the flexible
linker region.
doi:10.1371/journal.pone.0033586.g006
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